Médecins Sans Frontières On Drug Prices – You Can’t Negotiate Blindfolded 27/02/2019 Elaine Ruth Fletcher Katy Athersuch, Médecins Sans Frontières (MSF) Senior Policy Advisor – Medical Innovation & Access, spoke to Health Policy Watch about the recent proposal by Italy’s Minister of Health, Giulia Grillo, for a World Health Assembly resolution on transparency in drug pricing (Health Policy Watch 18 February). The far-reaching proposal asks countries to require disclosure by pharmaceutical companies of their R&D and, manufacturing costs, and public subsidies received, at the time a drug is registered. The resolution would also strengthen WHO’s role in global monitoring and assessment of available data on the costs and pricing of essential medicines. This is the first in a series of Q&As on the issue, looking towards April’s Fair Pricing Forum, where WHO member states will convene in South Africa, followed by the annual World Health Assembly in May. Continue reading -> WHO Rocks To The “Sound Of Life” At Launch Of WHO-ITU Safe Listening Standard 15/02/2019 David Branigan Grammy award-winning musician Ricky Kej performed a “Sound of Life” concert at the World Health Organization to help launch the first-ever global standard for safe listening devices, aimed at raising awareness and inspiring action to prevent sound-induced hearing loss. Continue reading -> WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New WHO-ITU Standard Released On “Safe Listening” To Prevent Hearing Loss 12/02/2019 David Branigan The World Health Organization and the International Telecommunication Union (ITU) have partnered to develop the first-ever international standard for “safe listening” devices, including smartphones and audio players, to raise awareness and to prevent sound-induced hearing loss. Over 1 billion teenagers and young adults are at risk of hearing loss around the world due to unsafe levels of sound, according to the WHO. Continue reading -> High Drug Prices Open Switzerland Up To Regional Procurement Ideas 07/02/2019 William New Switzerland, considered to be one of the richest countries in the world and home to significant medical research and development, has begun feeling the pressure of high drug prices for its citizens. This has led it to begin talking with other countries exploring joint procurement initiatives aimed at lowering prices, the Swiss global health ambassador told Health Policy Watch in a recent interview. Continue reading -> The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> WHO Recommends Cannabis Be Reclassified In UN Convention On Narcotic Drugs 07/02/2019 Elaine Ruth Fletcher The World Health Organization has recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention on Narcotic Drugs – a classification of drugs with “particularly dangerous properties”, including narcotics such as fentanyl, heroin and other opioids. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Posts navigation Older postsNewer posts
WHO Rocks To The “Sound Of Life” At Launch Of WHO-ITU Safe Listening Standard 15/02/2019 David Branigan Grammy award-winning musician Ricky Kej performed a “Sound of Life” concert at the World Health Organization to help launch the first-ever global standard for safe listening devices, aimed at raising awareness and inspiring action to prevent sound-induced hearing loss. Continue reading -> WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New WHO-ITU Standard Released On “Safe Listening” To Prevent Hearing Loss 12/02/2019 David Branigan The World Health Organization and the International Telecommunication Union (ITU) have partnered to develop the first-ever international standard for “safe listening” devices, including smartphones and audio players, to raise awareness and to prevent sound-induced hearing loss. Over 1 billion teenagers and young adults are at risk of hearing loss around the world due to unsafe levels of sound, according to the WHO. Continue reading -> High Drug Prices Open Switzerland Up To Regional Procurement Ideas 07/02/2019 William New Switzerland, considered to be one of the richest countries in the world and home to significant medical research and development, has begun feeling the pressure of high drug prices for its citizens. This has led it to begin talking with other countries exploring joint procurement initiatives aimed at lowering prices, the Swiss global health ambassador told Health Policy Watch in a recent interview. Continue reading -> The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> WHO Recommends Cannabis Be Reclassified In UN Convention On Narcotic Drugs 07/02/2019 Elaine Ruth Fletcher The World Health Organization has recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention on Narcotic Drugs – a classification of drugs with “particularly dangerous properties”, including narcotics such as fentanyl, heroin and other opioids. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Posts navigation Older postsNewer posts
WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New WHO-ITU Standard Released On “Safe Listening” To Prevent Hearing Loss 12/02/2019 David Branigan The World Health Organization and the International Telecommunication Union (ITU) have partnered to develop the first-ever international standard for “safe listening” devices, including smartphones and audio players, to raise awareness and to prevent sound-induced hearing loss. Over 1 billion teenagers and young adults are at risk of hearing loss around the world due to unsafe levels of sound, according to the WHO. Continue reading -> High Drug Prices Open Switzerland Up To Regional Procurement Ideas 07/02/2019 William New Switzerland, considered to be one of the richest countries in the world and home to significant medical research and development, has begun feeling the pressure of high drug prices for its citizens. This has led it to begin talking with other countries exploring joint procurement initiatives aimed at lowering prices, the Swiss global health ambassador told Health Policy Watch in a recent interview. Continue reading -> The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> WHO Recommends Cannabis Be Reclassified In UN Convention On Narcotic Drugs 07/02/2019 Elaine Ruth Fletcher The World Health Organization has recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention on Narcotic Drugs – a classification of drugs with “particularly dangerous properties”, including narcotics such as fentanyl, heroin and other opioids. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Posts navigation Older postsNewer posts
New WHO-ITU Standard Released On “Safe Listening” To Prevent Hearing Loss 12/02/2019 David Branigan The World Health Organization and the International Telecommunication Union (ITU) have partnered to develop the first-ever international standard for “safe listening” devices, including smartphones and audio players, to raise awareness and to prevent sound-induced hearing loss. Over 1 billion teenagers and young adults are at risk of hearing loss around the world due to unsafe levels of sound, according to the WHO. Continue reading -> High Drug Prices Open Switzerland Up To Regional Procurement Ideas 07/02/2019 William New Switzerland, considered to be one of the richest countries in the world and home to significant medical research and development, has begun feeling the pressure of high drug prices for its citizens. This has led it to begin talking with other countries exploring joint procurement initiatives aimed at lowering prices, the Swiss global health ambassador told Health Policy Watch in a recent interview. Continue reading -> The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> WHO Recommends Cannabis Be Reclassified In UN Convention On Narcotic Drugs 07/02/2019 Elaine Ruth Fletcher The World Health Organization has recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention on Narcotic Drugs – a classification of drugs with “particularly dangerous properties”, including narcotics such as fentanyl, heroin and other opioids. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Posts navigation Older postsNewer posts
High Drug Prices Open Switzerland Up To Regional Procurement Ideas 07/02/2019 William New Switzerland, considered to be one of the richest countries in the world and home to significant medical research and development, has begun feeling the pressure of high drug prices for its citizens. This has led it to begin talking with other countries exploring joint procurement initiatives aimed at lowering prices, the Swiss global health ambassador told Health Policy Watch in a recent interview. Continue reading -> The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> WHO Recommends Cannabis Be Reclassified In UN Convention On Narcotic Drugs 07/02/2019 Elaine Ruth Fletcher The World Health Organization has recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention on Narcotic Drugs – a classification of drugs with “particularly dangerous properties”, including narcotics such as fentanyl, heroin and other opioids. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Posts navigation Older postsNewer posts
The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> WHO Recommends Cannabis Be Reclassified In UN Convention On Narcotic Drugs 07/02/2019 Elaine Ruth Fletcher The World Health Organization has recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention on Narcotic Drugs – a classification of drugs with “particularly dangerous properties”, including narcotics such as fentanyl, heroin and other opioids. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Posts navigation Older postsNewer posts
WHO Recommends Cannabis Be Reclassified In UN Convention On Narcotic Drugs 07/02/2019 Elaine Ruth Fletcher The World Health Organization has recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention on Narcotic Drugs – a classification of drugs with “particularly dangerous properties”, including narcotics such as fentanyl, heroin and other opioids. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Posts navigation Older postsNewer posts
Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Posts navigation Older postsNewer posts
WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Posts navigation Older postsNewer posts
Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Posts navigation Older postsNewer posts